Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials
- PMID: 31004628
- PMCID: PMC6584030
- DOI: 10.1016/j.neubiorev.2019.03.023
Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials
Abstract
With growing interest in the gut microbiome, prebiotics and probiotics have received considerable attention as potential treatments for depression and anxiety. We conducted a random-effects meta-analysis of 34 controlled clinical trials evaluating the effects of prebiotics and probiotics on depression and anxiety. Prebiotics did not differ from placebo for depression (d = -.08, p = .51) or anxiety (d = .12, p = .11). Probiotics yielded small but significant effects for depression (d = -.24, p < .01) and anxiety (d = -.10, p = .03). Sample type was a moderator for probiotics and depression, with a larger effect observed for clinical/medical samples (d = -.45, p < .001) than community ones. This effect increased to medium-to-large in a preliminary analysis restricted to psychiatric samples (d = -.73, p < .001). There is general support for antidepressant and anxiolytic effects of probiotics, but the pooled effects were reduced by the paucity of trials with clinical samples. Additional randomized clinical trials with psychiatric samples are necessary fully to evaluate their therapeutic potential.
Keywords: Anxiety; Depression; Microbiome; Prebiotic; Probiotic.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures






Similar articles
-
From probiotics to psychobiotics - the gut-brain axis in psychiatric disorders.Benef Microbes. 2020 Dec 2;11(8):717-732. doi: 10.3920/BM2020.0063. Epub 2020 Nov 16. Benef Microbes. 2020. PMID: 33191776
-
Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain-Gut-Microbiome Axis.Biomolecules. 2021 Jul 7;11(7):1000. doi: 10.3390/biom11071000. Biomolecules. 2021. PMID: 34356624 Free PMC article. Review.
-
Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis.BMC Psychiatry. 2023 Jun 29;23(1):477. doi: 10.1186/s12888-023-04963-x. BMC Psychiatry. 2023. PMID: 37386630 Free PMC article.
-
The impact of probiotics, prebiotics, and synbiotics on depression and anxiety symptoms of patients with depression: A systematic review and meta-analysis.J Psychiatr Res. 2025 Aug;188:104-116. doi: 10.1016/j.jpsychires.2025.05.053. Epub 2025 May 24. J Psychiatr Res. 2025. PMID: 40440772 Review.
-
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.Diabetologia. 2021 Jan;64(1):26-41. doi: 10.1007/s00125-020-05295-1. Epub 2020 Oct 13. Diabetologia. 2021. PMID: 33047170
Cited by
-
Gut-Brain Axis Impact on Canine Anxiety Disorders: New Challenges for Behavioral Veterinary Medicine.Vet Med Int. 2024 Jan 23;2024:2856759. doi: 10.1155/2024/2856759. eCollection 2024. Vet Med Int. 2024. PMID: 38292207 Free PMC article. Review.
-
Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The "Gut Feelings" randomised controlled trial.Front Neurosci. 2023 Feb 6;16:1097278. doi: 10.3389/fnins.2022.1097278. eCollection 2022. Front Neurosci. 2023. PMID: 36815026 Free PMC article.
-
Development of the gut microbiota in healthy children in the first ten years of life: associations with internalizing and externalizing behavior.Gut Microbes. 2022 Jan-Dec;14(1):2038853. doi: 10.1080/19490976.2022.2038853. Gut Microbes. 2022. PMID: 35188073 Free PMC article.
-
Multispecies probiotic administration reduces emotional salience and improves mood in subjects with moderate depression: a randomised, double-blind, placebo-controlled study.Psychol Med. 2023 Jun;53(8):3437-3447. doi: 10.1017/S003329172100550X. Epub 2022 Feb 7. Psychol Med. 2023. PMID: 35129111 Free PMC article. Clinical Trial.
-
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities.CNS Neurol Disord Drug Targets. 2024;23(9):1085-1100. doi: 10.2174/0118715273254093231020052002. CNS Neurol Disord Drug Targets. 2024. PMID: 37885113 Review.
References
-
- Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, Memarzadeh MR, Asemi Z, Esmaillzadeh A, 2016. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32, 315–320. 10.1016/j.nut.2015.09.003 - DOI - PubMed
-
- Azpiroz F, Dubray C, Bernalier-Donadille A, Cardot J-M, Accarino A, Serra J, Wagner A, Respondek F, Dapoigny M, 2017. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: A randomized, double blind, placebo controlled study. Neurogastroenterol. Motil 29, e12911 10.1111/nmo.12911 - DOI - PubMed
-
- Biostat, 2014. Comprehensive Meta-Analysis Version 3.
-
- Chung YC, Jin HM, Cui Y, Kim DS, Jung JM, Park J Il, Jung ES, Choi EK, Chae SW, 2014. Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J. Funct. Foods 10, 465–474. 10.1016/j.jff.2014.07.007 - DOI